Table 4.
BI/H |
qPCR |
|||||
---|---|---|---|---|---|---|
Patients | Sensitivity (%) | PPV (%) | NPV (%) | Sensitivity (%) | PPV (%) | NPV (%) |
Total (n = 126) | 80.1 | 80.1 | 44.4 | 84.9 | 84.9 | 61.2 |
TT (n = 10) * | 37.5 | 37.5 | 61.5 | 52.5 | 52.5 | 86.3 |
BT (n = 10) * | 100 | 100 | 100 | 100 | 100 | 100 |
BB (n = 10) * | 100 | 100 | 100 | 100 | 100 | 100 |
BL (n = 10) * | 100 | 100 | 100 | 100 | 100 | 100 |
LL (n = 10) * | 100 | 100 | 100 | 100 | 100 | 100 |
RR (n = 10) * | 75 | 75 | 80 | 95 | 95 | 98.3 |
ENH (n = 10) * | 100 | 100 | 100 | 100 | 100 | 100 |
qPCR, real time PCR; BI/H, bacilloscopy of histological sections; PPV, positive predictive value; NPV, negative predictive value.
To avoid overrepresentation of the groups with small sample size, the sensitivity, PPV and NPV values for the individual groups (leprosy clinical forms and reactional forms) were calculated after a random selection of the samples to comprise groups with the equal n = 10.